文献速递功能神经外科脑血管病外科

微血管减压术治疗三叉神经痛:单中心516例经验,包括32例多发性硬化患者

Microvascular decompression for trigeminal neuralgia: a single-center experience with 516 cases, including 32 patients with multiple sclerosis.
PubMed 文献 · Acta Neurochir (Wien) · 2023-11-10

本研究回顾性分析2011年1月至2022年12月单中心516例接受微血管减压术的三叉神经痛患者,其中32例合并多发性硬化。复发率15.11%,再手术率12.98%,无术中死亡及重大术中并发症。作者认为微血管减压术可能为有效安全的手术方式,多发性硬化患者亦可考虑,但预后较经典三叉神经痛患者差,需更大样本研究。

要点

  • 多发性硬化亚组32例中21例(65.62%)达到BNI I级,预后较经典三叉神经痛差。
  • 复发率15.11%,再手术率12.98%,无术中死亡及重大术中并发症。

核心结论

  • 微血管减压术可能被认为是三叉神经痛有效且安全的手术技术。
  • 对于多发性硬化患者,即使预期预后较经典三叉神经痛患者差,微血管减压术仍可能被提出。
  • 需要更大规模的研究聚焦多发性硬化与神经血管压迫的关系。

研究设计与样本

  • 回顾性收集并分析2011年1月至2022年12月期间在本神经外科科室连续接受微血管减压术的516例三叉神经痛患者,所有患者MRI均诊断神经血管冲突。
  • 手术由10名不同年龄和经验的术者完成。
  • 收集并分析疼痛改善、再手术率和并发症发生率。

主要发现

  • 516例患者包括214例男性和302例女性,年龄范围12至87岁,其中32例患多发性硬化。
  • 术中所有病例均发现神经血管压迫。
  • 多发性硬化亚组32例中21例(65.62%)达到BNI I级评分。
  • 本系列疼痛复发率为15.11%,再手术率为12.98%;所有患者随访至少13个月,平均随访41.93个月(±17.75个月,范围13-91个月);分析系列中无术中死亡及重大术中并发症。

临床怎么用

  • 作者认为微血管减压术可能被认为是三叉神经痛有效且安全的手术技术。
  • 作者认为在多发性硬化患者中,即使预期预后较经典三叉神经痛患者差,微血管减压术仍可能被提出。
  • 作者指出需要更大规模的研究聚焦多发性硬化与神经血管压迫的关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To evaluate the effectiveness and long-term pain relief of microvascular decompression (MVD) for "typical" trigeminal neuralgia (TN), including patients affected by multiple sclerosis (MS). METHODS: Between January 2011 and December 2022, 516 consecutive patients presenting with trigeminal neuralgia and a diagnosed neurovascular conflict at MRI underwent microvascular decompression surgery in our neurosurgery department. Ten surgeons with different ages and experiences performed the surgical procedures. Pain improvement, re-operation rate, and complication rates were retrospectively collected and analyzed. RESULTS: 516 patients were included (214 males 302 females, ranging from 12 to 87 years), including 32 patients with multiple sclerosis. Neurovascular compression was found in all cases during surgery. Barrow Neurological Institute pain intensity scale with a score of I was achieved in 404 patients (78,29%), a score II or III was obtained in 100 cases (19,37%) and a score of IV and V in 12 patients (2,32%). In the multiple sclerosis subset of patients, a BNI score of I was achieved in 21/32 (65.62%). The pain recurrence rate of our series was 15.11%. The follow-up for all patients was at least of 13 months, with a mean follow-up of 41.93 months (± 17.75 months, range 13-91 months). Neither intraoperative mortality nor major intra-operative complications occurred in the analyzed series. The re-operation rate was 12.98%. Thermorhizotomy, percutaneous balloon compression, cyber-knife radiosurgery, or new MVD were the surgical techniques utilized for re-operations. CONCLUSIONS: MVD may be considered an effective and safe surgical technique for TN, and in patients affected by multiple sclerosis, it may be proposed even if a less favorable outcome has to be expected with respect to classic TN patients. Larger studies focusing on the relation of multiple sclerosis with neurovascular compression are required.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Castelli N, Innocenti N, Ferroli P, et al. Microvascular decompression for trigeminal neuralgia: a single-center experience with 516 cases, including 32 patients with multiple sclerosis. Acta Neurochir (Wien). 2023. PMID: 37945996. doi:10.1007/s00701-023-05872-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。